Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
NT$ 36.95
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Strong margins and returns
Data is available to registered users only
Data is available to registered users only
About
Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide. Its products include trocars, single port surgery devices, and wound protectors; endo devices, such as hand instruments and advanced bipolar devices; specimen retrieval products; suction irrigation systems and irrigation pumps; training systems; and...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT
Data is available to registered users only
Buy
Sell